Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Cancer

Last data update: Mar 21, 2023. (Total: 58828 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 154 Records)

Next

Query Trace: Pancreatic Cancer[original query]>>Reviews/Commentaries[Product Type]
Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans.
Guettchina Telisnor et al. Journal of the National Medical Association 2023
Artificial intelligence in pancreatic cancer: diagnosis, limitations, and the future prospects-a narrative review.
Maanya Rajasree Katta et al. Journal of cancer research and clinical oncology 2023
FAMILIAL PANCREATIC CANCER.
Nero Lorenzo Del et al. Clinics and research in hepatology and gastroenterology 2023 102079
Pancreatic Cancer: Beyond Brca Mutations
V Ricci et al, J Per Med, December 16, 2022
Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening.
Badheeb Mohamed et al. Current oncology (Toronto, Ont.) 2022 29(11) 8693-8719
Targeting KRAS in Pancreatic Cancer
D Cowser et al, J Per Med, November 8, 2022
Familial Pancreatic Cancer.
Saba Helena et al. Gastroenterology clinics of North America 2022 51(3) 561-575
Current Screening Strategies for Pancreatic Cancer.
Vanek Petr et al. Biomedicines 2022 10(9)
Artificial intelligence for the detection of pancreatic lesions.
Anta Julia Arribas et al. International journal of computer assisted radiology and surgery 2022
Application of artificial intelligence to pancreatic adenocarcinoma.
Chen Xi et al. Frontiers in oncology 2022 12960056
Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care.
Casolino Raffaella et al. Cancers 2022 14(13)
Point/Counterpoint: Is It Time for Universal Germline Genetic Testing for all GI Cancers?
Hampel Heather et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 JCO2102764
BRCA-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms.
Devico Marciano Naomie et al. Cancers 2022 14(10)
Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool.
Sammallahti Heidelinde et al. Biomolecules 2022 12(5)
Using Quantitative Imaging for Personalized Medicine in Pancreatic Cancer: A Review of Radiomics and Deep Learning Applications.
Preuss Kiersten et al. Cancers 2022 14(7)
Translational advances in pancreatic ductal adenocarcinoma therapy.
Hosein Abdel Nasser et al. Nature cancer 2022 3(3) 272-286
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?
Morgan Robert D et al. British journal of cancer 2022
Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.
Kasuga Akiyoshi et al. International journal of molecular sciences 2022 23(3)
Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data
AA Connor et al, Nat Rev Cancer, November 17, 2021
Inherited Pancreatic Cancer Syndromes and High-Risk Screening.
Biller Leah H et al. Surgical oncology clinics of North America 2021 30(4) 773-786
BRCA mutations in pancreatic cancer and progress in their targeting.
Alkassis Samer et al. Expert opinion on therapeutic targets 2021
The pancreatic cancer genome revisited.
Hayashi Akimasa et al. Nature reviews. Gastroenterology & hepatology 2021 18(7) 469-481
Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules.
Jimenez-Sainz Judit et al. Genes 2021 12(5)
BRCA2: a 25-year journey from gene identification to targeted cancer treatment.
Grinda Thomas et al. The Lancet. Oncology 2021 22(6) 763-764
Comprehensive analysis of DNA damage repair genes reveals pathogenic variants beyond BRCA and suggests the need for extensive genetic testing in pancreatic cancer.
Rapposelli Ilario Giovanni et al. BMC cancer 2021 21(1) 611
Genetic Variants in Patients With a Family History of Pancreatic Cancer: Impact of Multigene Panel Testing.
Zhu Huili et al. Pancreas 2021 50(4) 602-606
Inherited predisposition to pancreatic cancer.
Hilfrank Kimberly J et al. Seminars in oncology 2021
Genetic Abnormalities in Pancreatitis: An Update on Diagnosis, Clinical Features, and Treatment.
Suzuki Mitsuyoshi et al. Diagnostics (Basel, Switzerland) 2020 Dec 11(1)
Looking to Long-term Survivors for Improved Pancreatic Cancer Treatment
BM Kuehn, JAMA, November 18, 2020
Retrospective review of outcomes in patients with DNA-damage repair related pancreatic cancer.
Macklin-Mantia Sarah K et al. Hereditary cancer in clinical practice 2020 1817
TOP